XOMA Corp (XOMAP)
XOMA.P is a preferred stock listing associated with XOMA Corp on NASDAQ. The underlying issuer, now known as XOMA Royalty Corporation, is a biotechnology-focused company that operates as a royalty aggregator. Its business centers on economic rights tied to future milestone and royalty payments from commercial products and therapeutic candidates at various stages of development. The company also targets early- to mid-stage clinical assets, particularly Phase 1 and Phase 2 programs with potential for commercial sales, and acquires revenue streams linked to late-stage clinical and commercial assets. XOMA Royalty maintains a portfolio of such assets across the United States, Switzerland, the Asia Pacific, and Australia. The company was incorporated in 1981 and is headquartered in Emeryville, California.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-XOMAP
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
2.16
|
—
|
August 11, 2026
|
35.6x
|
7.7x
|
14.6x
|
710.2 M
|
—
|
14.6%
|
7.0%
|
-4.1
|
16.4%
|
34.1%
|